
0:41
Dr. Charles Mok argues that low testosterone in men goes almost entirely untreated despite being inexpensive to address. He claims TRT reduces cardiac mortality and adds roughly 10% to lifespan for men with low testosterone.

Dr. Charles Mok argues that low testosterone in men goes almost entirely untreated despite being inexpensive to address. He claims TRT reduces cardiac mortality and adds roughly 10% to lifespan for men with low testosterone.
There's a whole large group of men that don't have those symptoms and don't have such severely low testosterone. And today, 99% of them aren't being treated, maybe higher percentage than that. So this is a big say, disservice to men in our country for a drug that's pretty cheap, that you could pay for on your own, that your doctor can prescribe, that reduces cardiac mortality substantially, may extend your life about 10% in men with low testosterone. So I think this is something we really need to realize that as physicians, we're under diagnosing testosterone, low testosterone, because the assumption that the insurance company doesn't pay, in other words, if it's not free, men can't have it. You can get stuff that's not covered by insurance. Your doctor is totally allowed to prescribe it in the right setting.

Functional Movement vs Traditional Physical Therapy #shorts #mobility #physicaltherapy

Knee Arthritis? It Might Not Be Your Knee #kneepain #jointpain #arthritis #shorts

Lifestyle vs Medication: A Smarter Approach to Heart Health #shorts #hearthealth

How to Build a Strong, Healthy Back for Longevity (Before Pain Starts) #muscle #shorts #longevity